The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N07 | Other nervous system drugs | |
| 3 | N07X | Other nervous system drugs | |
| 4 | N07XX | Other nervous system drugs | |
| 5 | N07XX14 |
| Active Ingredient | Description | |
|---|---|---|
| Edaravone |
Edaravone is a member of the substituted 2-pyrazolin-5-one class. It is used for the treatment of amyotrophic lateral sclerosis (ALS). The mechanism by which edaravone exerts its therapeutic effect in patients with ALS is unknown. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| RADICAVA Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
